Oracle Corp. said final negotiations on an equity deal for a data center project in Michigan are “on schedule” and doesn’t ...

Weaker-than-forecast quarterly data for Larry Ellison’s tech company shows slowdown in revenue growth and big rise in spending Business live – latest updates Oracle’s shares tumbled 15% on Thursday in ...

Shares in the technology company are down as investors grow anxious that its bet on artificial intelligence, and OpenAI in particular, may not pay off. By Andrew Ross Sorkin Bernhard Warner Sarah ...

Oracle bonds take hit after reports of debt takeout Investors concerned over commitments to AI Others question depreciation accounting of AI buildout Nov 14 (Reuters) - Oracle bonds have taken a hit ...

Oracle Corporation is rated a Buy with a $280 price target, suggesting 17% upside driven by AI and cloud momentum. ORCL's cloud revenue surged 28% YoY, fueled by a $300B OpenAI deal and $455B in ...

Oracle stock (NYSE: ORCL) has dropped 7% in a day, currently priced at $257. This decline appears to be due to profit-taking after the stock had soared over 80% in the past six months, largely driven ...

Tech giant Oracle has reverted to a dual-CEO system that defies conventional wisdom, but it has broken tradition before in its evolution from databases to software, cloud-computing and AI ...

From plans to embed OpenAI technology into its patient portal to expanding its collaboration with Ascension, here’s a look at how EHR giant Oracle Health is growing and forging new partnerships in ...

Oracle has reinvented itself as a leading AI infrastructure platform, driving a significant surge in share price and market relevance. ORCL's cloud segment, including Oracle Cloud Infrastructure, is ...

Oracle boasts high revenue visibility in the coming years. The increasing demand for AI-powered cloud infrastructure and AI databases is driving Oracle’s growth. High-profile deals have further made ...

Being told that you have elevated cholesterol can feel like a letdown on an otherwise good bill of health. But you aren’t alone—according to the U.S. Centers for Disease Control and Prevention (CDC), ...

Bond investors aren’t known for seeking out excitement. When it comes to the kind of metrics fixed income traders are looking for to sell to their clients, bland is a lot more attractive than bold.